InsidersTradesSigma
BioArctic AB: directors' dealings · Finland · FIN-FSA
FI:bioarctic-ab-a6f0acSE0010323311FI·FIN-FSAMcap 27.7Bn€Healthcare
Explore the full management transaction log of BioArctic AB, a publicly traded company based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, BioArctic AB has published 4 reports. Market capitalisation: €27.7bn. The latest transaction was filed on 19 December 2025 — Sale. Among the most active insiders: Pär Gellerfors. All data is free.
4
Insider Decl.
0
Thresholds
€10,308
2 ops.
Buy Volume
€10m
2 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
312.20 €
Analyst consensus
5 analystsHold
240.00 €Target 301.40 €(-3%)355.00 €
Income statement
Revenue2.00 Bn€
Gross profit1.94 Bn€97% margin
Net income1.02 Bn€51.1% margin
Valuation
PER (trailing)27.1x
PER (forward)39.6x
P/Book14.1x
Beta-0.78
Balance sheet & cash
Market cap27.70 Bn€
Total debt44.1 M€
Free Cash Flow1.42 Bn€
Debt / Equity2%
Profitability & ownership
ROE71.4%
ROA46.4%
% insiders42.7%
% institutions34.0%
Last declaration on 19 December 2025
Declarations4 total
Executives●Sale23FIN-FSA
€5m173,750 shares@ €28.36530.018% mcap100.0% of flow
Aktie
FI:A003U936-1·
Executives●Sale23FIN-FSA
€5m173,750 shares@ €28.36530.018% mcap100.0% of flow
Aktie
FI:A003U935-1·
Executives●Purchase20FIN-FSA
€2,905198 shares@ €14.67120.0000% mcap100.0% of flow
Aktie
FI:A003N413-1·
Ideal exit: 11 Jan 2026 (T+270)
Executives●Purchase32FIN-FSA
€7,403500 shares@ €14.8060.0000% mcap100.0% of flow
Aktie
FI:A003N411-1·
Ideal exit: 11 Jan 2026 (T+270)
4 of 4 declarations